Summary
- Current Price
- As of today, MGX price is $1.33, unchanged in the most recent trading session on
- Current Price All-Time High
- MGX price is currently -89.56% below its historical high of $12.74 set on
- Market Cap
- MGX current market cap is $50M, down -21.21% year-over-year
- PE Ratio
- MGX PE ratio is unknown
- Revenue
- MGX current annual revenue is $25.21M, down -51.79% year-over-year
- Next Earnings
- As of today, the next earnings release for MGX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Metagenomi Therapeutics, Inc. |
| Ticker | NASDAQ: MGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | metagenomi.co |
| Employees | 119 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.33 | ||
| Price, 1D Change | 0.00% | |
| $50M | ||
| - | ||
| - | ||
| 2.24 | ||
| $25M | ||
| Revenue, 1Y Change | -51.79% | |
| -$2.36 | ||
| EPS, 1Y Change | -13.07% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.36 | ||
| EPS Estimate | N/A | -$2.11 |
| EPS Est. Change | N/A | +10.55% |
| $25.21M | ||
| Revenue Estimate | N/A | $12.15M |
| Revenue Est. Change | N/A | -51.81% |
| $1.33 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +501.50% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.48 | -$2.09 | +15.97% | |
| -$2.34 | -$2.36 | -0.91% | |
| -$2.11 | N/A | +10.55% | |
| -$1.47 | N/A | +37.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $51.70M | $52.30M | +1.15% | |
| $28.63M | $25.21M | -11.94% | |
| $12.15M | N/A | -51.81% | |
| $12.52M | N/A | -50.33% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -21.76% | ||
| - | ||
| -21.21% | ||
| - | ||
| -51.79% | ||
| +46.57% | ||
| -13.07% | ||
| -102.77% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $1.33 | ||
| $1.78 | ||
| $1.38 | ||
| $1.73 | ||
| $1.40 | ||
| -$0.02 | ||
| 2.24 | ||
| $0.07 | ||
| 46.13 | ||
| 39.80% | ||
| 73.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $25.21M | ||
| -$2.36 | ||
| $19.89M | ||
| 78.91% | ||
| -$96.01M | ||
| -380.85% | ||
| -$87.87M | ||
| -348.54% | ||
| -$90.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.26 | ||
| 7.22 | ||
| 7.22 | ||
| - | ||
| 2 | ||
| -1.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.24 | ||
| 0.36 | ||
| 0.58 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $158.60M | ||
| $160.80M | ||
| $233.28M | ||
| $165.54M | ||
| $74.68M | ||
| $22.93M | ||
| $40.66M | ||
| $6.03M | ||
| $1.49M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $113.08M | ||
| $115.91M | ||
| $5.32M | ||
| $0.00 | ||
| $5.32M | ||
| $0.00 | ||
| -$58.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$88.89M | ||
| $103.53M | ||
| -$356.00K | ||
| $574.00K | ||
| -$89.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with MGX
FAQ
What is the ticker symbol for Metagenomi Therapeutics, Inc.?
The ticker symbol for Metagenomi Therapeutics, Inc. is NASDAQ:MGX
Does Metagenomi Therapeutics, Inc. pay dividends?
No, Metagenomi Therapeutics, Inc. does not pay dividends
What sector is Metagenomi Therapeutics, Inc. in?
Metagenomi Therapeutics, Inc. is in the Healthcare sector
What industry is Metagenomi Therapeutics, Inc. in?
Metagenomi Therapeutics, Inc. is in the Biotechnology industry
What country is Metagenomi Therapeutics, Inc. based in?
Metagenomi Therapeutics, Inc. is headquartered in United States
When did Metagenomi Therapeutics, Inc. go public?
Metagenomi Therapeutics, Inc. initial public offering (IPO) was on April 6, 2006
Is Metagenomi Therapeutics, Inc. in the S&P 500?
No, Metagenomi Therapeutics, Inc. is not included in the S&P 500 index
Is Metagenomi Therapeutics, Inc. in the NASDAQ 100?
No, Metagenomi Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Metagenomi Therapeutics, Inc. in the Dow Jones?
No, Metagenomi Therapeutics, Inc. is not included in the Dow Jones index
When was Metagenomi Therapeutics, Inc. last earnings report?
Metagenomi Therapeutics, Inc.'s most recent earnings report was on August 13, 2025
When does Metagenomi Therapeutics, Inc. report earnings?
The date for Metagenomi Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MGX Official Website metagenomi.co
- MGX Profile on Yahoo Finance finance.yahoo.com/quote/MGX
- MGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mgx